Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Artiva Biotherapeutics Inc., 2 years.
Artiva Biotherapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 17, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −10,172 | $73.21 | $744,692 |
| Mar 16, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +60,299 | $60.89 | $3,671,606 |
| Mar 16, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +61,041 | $56.78 | $3,465,908 |
| Mar 16, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +33,118 | $32.60 | $1,079,647 |
| Mar 16, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +20,541 | $37.58 | $771,931 |
| Mar 16, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −205,608 | $72.38 | $14,881,907 |
| Mar 16, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −9,440 | $72.77 | $686,949 |
| Jan 30, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −6,988 | $83.24 | $581,681 |
| Jan 29, 2026 | Ionis Pharmaceuticals Inc. | Grant or award | +13,562 | — | — |
| Jan 16, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −12,922 | $75.22 | $971,993 |
| Jan 15, 2026 | Ionis Pharmaceuticals Inc. | Option exercise | +28,729 | — | — |
| Sep 30, 2025 | Ionis Pharmaceuticals Inc. | Option exercise | +49,800 | $53.77 | $2,677,746 |
| Sep 30, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −49,800 | $65.26 | $3,249,948 |
| Jan 31, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −1,523 | $32.44 | $49,406 |
| Jan 30, 2025 | Ionis Pharmaceuticals Inc. | Grant or award | +4,138 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.